Advanced Prostate Cancer – Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

UROwebinar Evolving interventional therapy for bladder outlet obstruction in men. Where do we stand?

EAU Guidelines on Paediatric Urology

E-BRUS

EAU Guidelines on Renal Transplantation

Second-line therapy in metastatic ccRCC

UROwebinar COVID-19 recommendations for onco-urologists

UROwebinar Augmented reality & robotic surgery

UROwebinar COVID-19 and urological management of stone disease

RCC - Management of small renal masses

UROwebinar The New EAU Male Sexual and Reproductive health Guidelines – Male Hypogonadism and Male Infertility

SIU uRCADE featuring the I-O+ Challenger and RCC Quest - APP

Prostate cancer - Prostate cancer imaging and biopsy: When and how to use it

Progress in Prostate Cancer: Beginning With the End in Mind

Timely Therapies in Disease of the Prostate: What's Your Practice?MedScape

Andrological diagnostics before reproductive medical treatment

Sporadic Creutzfeldt-Jakob Disease Among Physicians, Germany, 1993–2018

Discussion: First-Line Treatment of a Patient With Unresectable/Metastatic Bladder Cancer: The Impact and Options Based on PD-L1 Status and Platinum Eligibility

Botulinum toxin for overactive bladder

Recent Advances in the Treatment Landscape for the Patient With BCG- Unresponsive NMIBC

Virtual Grand Rounds: A Monthly Series of Bladder Cancer Cases

Advancing Our Understanding of OAB: Optimizing Management Strategies for Frail and Older Adults

ADT for Prostate Cancer Requires Earlier Administration

Urothelial carcinoma of the upper urinary tract

24 hours of COVID-19 /Chasing the Sun

The Changing Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2020)

Differentiating GnRH Antagonists From GnRH Agonists: What Are the Latest Data in Prostate Cancer Showing?

Hospital hygiene 2.0 - Der Urologe Springer

Systemic therapy of advanced prostate cancer - Der Urologe Springer

Advanced Cardiac Life Support (ACLS)

Targeted Alpha Therapies in Prostate Cancer

Renal Cell Carcinoma: Immunotherapy-Based Treatments, Risk Stratification, and Review of Treatment Approaches

Tumor Board: PARP Inhibition in Prostate Cancer Management

Personalizing Hormonal Therapies in Prostate Cancer: Case Reviews

Treatment Across the Prostate Cancer Continuum: Current Practice and Future Directions

Using PSMA in Prostate Cancer Management: Is Your Practice Prepared?

Immune Checkpoint and PARP Inhibitors in Prostate Cancer: Will This Combination Benefit Patients?

MedScape: On the Horizon: PSMA Radioligand Therapies in Prostate Cancer

Take the Challenge: Putting Your Practice for Prostate Cancer to the Test

Antibiotic prophylaxis in endourological procedures considering antibiotic stewardship.

SPRINGERCME: Systemic therapy of bladder cancer - Der Urologe Springer

ESU-ESUT Masterclass on Urolithiasis

B2B Men’s Health